Company Filing History:
3 out of 1,743 
1 out of 237 
1 out of 1 
Years Active: 2015-2024
Title: Aurélien De Reynies: Innovator in Cancer Research
Introduction
Aurélien De Reynies is a prominent inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in the identification and prognosis of prostate and liver cancers. With a total of 3 patents, his work is paving the way for advancements in medical diagnostics.
Latest Patents
One of his latest patents is titled "Molecular signature and use thereof for the identification of indolent prostate cancer." This innovative method predicts the risk of prostate cancer recurrence by analyzing a sample from the patient. The process involves determining the TMPRSS/ERG fusion status and measuring the expression levels of various prostate cancer markers. By comparing the molecular signature to a reference signature, the method assigns the patient to a risk group, thereby predicting the likelihood of cancer recurrence.
Another significant patent is "Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen." This invention outlines a method to determine the gene expression profile from a liver tumor sample. It enables the assessment of tumor grade, such as hepatoblastoma or hepatocellular carcinoma, and helps in defining the appropriate therapeutic regimen for patients. The invention also includes kits with specific probes for gene analysis, enhancing the accuracy of tumor grading and treatment planning.
Career Highlights
Aurélien De Reynies has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale) and Sorbonne University. His experience in these organizations has contributed to his expertise in cancer research and molecular diagnostics.
Collaborations
Throughout his career, Aurélien has collaborated with notable colleagues, including Olivier Cussenot and Aurélie Kamoun. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in cancer diagnostics.
Conclusion
Aurélien De Reynies is a dedicated inventor whose work in cancer research is making a significant impact. His innovative patents and collaborations are advancing the field of medical diagnostics, particularly in understanding and treating prostate and liver cancers.